Shamburg News · 8-K filed Oct 16, 2026, 9:17 AM EDT
OSR Health Amends VXM01 License Agreement with BCM Europe to Add Convertible Note Option
OSRH · OSR Health, Inc.
- Material agreement
- Financing
- Materiality: high
On October 15, 2026, OSR Health, Inc., its subsidiary Vaximm AG, and BCM Europe AG entered into Amendment No. 1 to the Global Exclusive License Agreement for VXM01. The amendment adds Section 6.10, allowing the company to convert all or part of an unexercised $15,000,000 equity put option into convertible notes issued in four $3,750,000 tranches with fixed conversion prices of approximately $2.00, $3.00, $4.00 and $5.00 per share. The amendment references a Nasdaq Staff delisting determination dated August 19, 2026.
Source: SEC EDGAR, Form 8-K, Items 1.01, 9.01, accession 0001213900-26-110051.
Written from the filing by Shamburg Markets. Figures are as reported by the company.